Literature DB >> 16314136

Thymoquinone: a promising anti-cancer drug from natural sources.

Hala Gali-Muhtasib1, Albert Roessner, Regine Schneider-Stock.   

Abstract

There has been growing interest in naturally occurring compounds with anti-cancer potential. Black seed is one of the most extensively studied plants. This annual herb grows in countries bordering the Mediterranean Sea and India. Thymoquinone (TQ) is the bioactive constituent of the volatile oil of black seed. It has been shown to exert anti-neoplastic and anti-inflammatory effects. The molecular pathways of TQ action are not clear. Nevertheless, TQ is known to induce apoptosis by p53-dependent and p53-independent pathways in cancer cell lines. Growth inhibition is associated with induction of cell cycle arrest. TQ also acts on the immune system by modulating the levels of inflammatory mediators. To date, the chemotherapeutic potential of TQ in the clinic has not been tested, but numerous studies have shown its promising anti-cancer effects in animal models. The combination of TQ with clinically used anti-cancer drugs has led to improvements in their therapeutic index and prevents non-tumor tissues from sustaining chemotherapy-induced damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314136     DOI: 10.1016/j.biocel.2005.10.009

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  80 in total

Review 1.  Review on molecular and therapeutic potential of thymoquinone in cancer.

Authors:  Sanjeev Banerjee; Subhash Padhye; Asfar Azmi; Zhiwei Wang; Philip A Philip; Omer Kucuk; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.

Authors:  Maria P Torres; Moorthy P Ponnusamy; Subhankar Chakraborty; Lynette M Smith; Srustidhar Das; Hwyda A Arafat; Surinder K Batra
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

Review 3.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

4.  Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.

Authors:  El-Shaimaa A Arafa; Qianzheng Zhu; Zubair I Shah; Gulzar Wani; Bassant M Barakat; Ira Racoma; Mohamed A El-Mahdy; Altaf A Wani
Journal:  Mutat Res       Date:  2010-10-30       Impact factor: 2.433

5.  Anti-neoplastic agent thymoquinone induces degradation of α and β tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts.

Authors:  Mahmoud Alhosin; Abdulkhaleg Ibrahim; Abdelaziz Boukhari; Tanveer Sharif; Jean-Pierre Gies; Cyril Auger; Valérie B Schini-Kerth
Journal:  Invest New Drugs       Date:  2011-09-01       Impact factor: 3.850

6.  The hepatoprotective activity of olive oil and Nigella sativa oil against CCl4 induced hepatotoxicity in male rats.

Authors:  Madeha N Al-Seeni; Haddad A El Rabey; Mazin A Zamzami; Abeer M Alnefayee
Journal:  BMC Complement Altern Med       Date:  2016-11-04       Impact factor: 3.659

Review 7.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

8.  The effect of thymoquinone on the renal functions following ischemia-reperfusion injury in the rat.

Authors:  Fayez T Hammad; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-12-25

9.  Attenuation of the development of hypercholesterolemic atherosclerosis by thymoquinone.

Authors:  Ahmed Ragheb; Fawzy Elbarbry; Kailash Prasad; Adel Mohamed; Mohamed S Ahmed; Ahmed Shoker
Journal:  Int J Angiol       Date:  2008

10.  In vitro study of the cytotoxicity of thymoquinone/curcumin fluorescent liposomes.

Authors:  Heba Mohamed Fahmy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.